文献速递临床生化临床免疫

循环脂肪细胞脂肪酸结合蛋白浓度预测糖尿病患者多种死亡结局

Circulating Adipocyte Fatty Acid-Binding Protein Concentrations Predict Multiple Mortality Outcomes among Men and Women with Diabetes.
PubMed 文献 · Clin Chem · 2018-07-18

该研究在5305例2型糖尿病患者中,用单克隆抗体夹心免疫分析法检测基线血清AFABP浓度,并通过多变量Cox回归分析评估其与死亡结局的关系。中位随访5年期间共512例死亡(19.3例/1000人年)。循环AFABP浓度可预测全因死亡(P < 0.001)、心血管死亡(P = 0.037)和感染相关死亡(P < 0.002),且在男女中均为全因死亡的独立预测因子。

要点

  • 血清AFABP浓度可独立预测2型糖尿病患者的全因死亡、心血管死亡和感染相关死亡。
  • AFABP对癌症死亡和感染相关死亡的预测仅在男性中显著。
  • 将AFABP加入模型可改善2型糖尿病患者全因死亡的时间依赖C统计量(P = 0.008)。

核心结论

  • 循环AFABP浓度是2型糖尿病患者多种死亡结局的独立预测因子,独立于已知的生存风险因素,且在男女中均成立。

研究设计与样本

  • 研究基于大型临床队列,纳入5305例2型糖尿病患者(59%为男性),采用单克隆抗体夹心免疫分析法检测基线血清AFABP浓度。
  • 通过多变量Cox回归分析评估AFABP浓度对死亡结局的预测作用。

主要发现

  • 中位随访5年期间共发生512例死亡(19.3例/1000人年)。
  • 基线时女性AFABP水平高于男性。
  • 在所有参与者中,AFABP浓度预测全因死亡(P < 0.001)、心血管死亡(P = 0.037)和感染相关死亡(P < 0.002)。
  • 性别特异性分析中,AFABP是男女全因死亡的独立预测因子,但仅男性中预测癌症相关死亡和感染相关死亡。
  • 加入血清AFABP浓度可改善2型糖尿病患者全因死亡预测的时间依赖C统计量(P = 0.008)。

临床怎么用

  • 在2型糖尿病患者中,检测血清AFABP浓度可能有助于识别死亡风险较高的个体,尤其是全因死亡、心血管死亡和感染相关死亡风险。
  • AFABP作为预后生物标志物和治疗靶点的作用尚需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Raised circulating adipocyte fatty acid-binding protein (AFABP) concentrations are associated with various adverse health conditions. However, their relationship with mortality remains to be defined, especially in view of the sexual dimorphism of circulating AFABP concentrations. Here we investigated prospectively whether serum AFABP concentrations predict multiple mortality outcomes in men and women alike, using a large clinic-based cohort of individuals with type 2 diabetes, a condition with raised AFABP concentrations. METHODS: Baseline serum AFABP concentrations were measured in 5305 research participants with a monoclonal antibody-based sandwich immunoassay. The role of circulating AFABP concentrations in predicting mortality outcomes was evaluated by multivariable Cox regression analysis. RESULTS: Among the 5305 participants (59% men) in this study, over a median follow-up of 5 years, there were 512 deaths (19.3 deaths per 1000 person-years). Circulating AFABP concentrations, with higher levels in women at baseline, predicted all-cause mortality (P < 0.001), cardiovascular mortality (P = 0.037), and infection-related deaths (P < 0.002) among all participants. In sex-specific analyses, circulating AFABP concentration was an independent predictor of all-cause mortality in both men and women and a predictor of cancer-related deaths and infection-related deaths in men only. Furthermore, the addition of serum AFABP concentrations improved the time-dependent c statistics in predicting all-cause mortality in participants with type 2 diabetes (P = 0.008). CONCLUSIONS: Circulating AFABP concentration was an independent predictor of various mortality outcomes in type 2 diabetes over and above known risk factors of reduced survival in men and women. The role of AFABP as a prognostic biomarker and therapeutic target warrants further investigation.

来源:Clin Chem,查看原文。版权归原作者所有。

引用

  1. Lee CH, Cheung CYY, Woo YC, et al. Circulating Adipocyte Fatty Acid-Binding Protein Concentrations Predict Multiple Mortality Outcomes among Men and Women with Diabetes. Clin Chem. 2018. PMID: 30021923. doi:10.1373/clinchem.2018.289157

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。